Skip to main content
Amar Kishan, MD, Radiation Oncology, Los Angeles, CA

Amar Upadhyaya Kishan MD


Assistant Professor of Radiation Oncology

Join to view full profile
  • 200 Medical Plaza, Suite B265Los Angeles, CA 90095

  • Phone+1 310-825-9771

  • Fax+1 310-825-9771

Dr. Kishan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2013 - 2017
  • Scripps Mercy Hospital
    Scripps Mercy HospitalInternship, Transitional Year, 2012 - 2013
  • Harvard Medical School
    Harvard Medical SchoolClass of 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2028
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized,...  
    James B Yu, Amar U Kishan, JAMA Network Open

Press Mentions

  • Addition of Hormone Therapy to Postoperative Radiotherapy in Prostate Cancer
    Addition of Hormone Therapy to Postoperative Radiotherapy in Prostate CancerMarch 3rd, 2026
  • How Long Should Hormone Therapy Last for Prostate Cancer?
    How Long Should Hormone Therapy Last for Prostate Cancer?November 27th, 2025
  • Shorter Hormone Therapy May Be Enough for Many Men with Prostate Cancer
    Shorter Hormone Therapy May Be Enough for Many Men with Prostate CancerNovember 24th, 2025

Grant Support

  • Reducing toxicity from prostate cancer radiotherapy through genetics and technologyUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: